They have been identified through their expression of specific cell surface markers, such as CD34+CD38− was associated with AML(2); CD44+CD24− was for breast tumors(3); and CD44+CD24−ESA+ was for pancreatic tumors(4). Here, CD44 is linked to acute myeloid leukemia.